School of Medicine
Showing 6,851-6,860 of 12,989 Results
-
Matthew Lungren
Adjunct Professor, Biomedical Data Science
BioDr. Matthew Lungren is a physician-scientist and AI leader whose work has helped shape modern multimodal healthcare AI from early research through large-scale deployment. He joined Stanford University in 2014 as clinical research faculty, where he led a fully dedicated pediatric interventional radiology clinical service and established an NIH- and industry-supported clinical AI research program that helped catalyze what became the Stanford Center for AI in Medicine & Imaging. He remains an Adjunct Professor of Biomedical Data Science at Stanford and also holds a part-time clinical appointment at UCSF.
Dr. Lungren has authored more than 200 peer-reviewed publications with more than 35,000 citations, and he has taught more than 100,000 learners through AI-in-healthcare courses across platforms including Coursera and LinkedIn Learning. His broader contributions include advancing multimodal imaging-plus-EHR approaches, open-sourcing AI-ready medical imaging datasets and models, and serving in national leadership roles across the radiology AI community. After a sabbatical in 2021, he transitioned from academia to industry and joined Microsoft, where he served in senior leadership roles including Chief Scientific Officer for Microsoft Health & Life Sciences. At Microsoft, he founded and led cross-company teams that shipped multimodal healthcare foundation models and agentic, auditable generative AI workflows into production, including healthcare agent orchestration capabilities and major EHR partnerships, and led the health and life sciences partnerships with OpenAI.
Dr. Lungren is also a top rated instructor leading AI in Healthcare courses designed especially for learners with non-technical backgrounds:
Stanford/Coursera: https://www.coursera.org/learn/fundamental-machine-learning-healthcare
LinkedIn Learning: https://www.linkedin.com/learning/an-introduction-to-how-generative-ai-will-transform-healthcare -
Mitchell R. Lunn
Associate Professor of Medicine (Nephrology) and, by courtesy, of Epidemiology and Population Health
Current Research and Scholarly InterestsLGBTQIA+ health
-
Liqun Luo
Ann and Bill Swindells Professor and Professor, by courtesy, of Neurobiology
Current Research and Scholarly InterestsWe study how neurons are organized into specialized circuits to perform specific functions and how these circuits are assembled during development. We have developed molecular-genetic and viral tools, and are combining them with transcriptomic, proteomic, physiological, and behavioral approaches to study these problems. Topics include: 1) assembly of the fly olfactory circuit; 2) assembly of neural circuits in the mouse brain; 3) organization and function of neural circuits; 4) Tool development.
-
Ruben Y. Luo
Assistant Professor of Pathology
Current Research and Scholarly InterestsApply top-down mass spectrometry and label-free immunoassay to the study and utilization of biomarker proteoforms in clinical diagnosis.
-
Xiangde Luo
Postdoctoral Scholar, Radiation Physics
BioXiangde Luo is a postdoctoral researcher in Professor Ruijiang Li’s lab at Stanford Medicine, where he specializes in computational pathology. His work centers on developing AI‑driven methods for imaging biomarker discovery and precision oncology. Previously, he has developed some deep learning models to enable annotation‑efficient learning and advance biomedical image analysis. For a comprehensive overview of my research, please visit my Google Scholar profile: https://scholar.google.com/citations?hl=en&user=dD4HLS4AAAAJ. If you’d like to learn more or discuss potential collaborations, please don’t hesitate to get in touch.
-
XIAOHUA LUO
Affiliate, Institute for Immunity, Transplantation, and Infection Operations
Visiting Scholar, Institute for Immunity, Transplantation, and Infection OperationsBioAcademic Appointments
- Visiting Scholar, Stanford University School of Medicine (Holden Maecker Lab)
- Chief Physician / Associate Professor / Associate Research Scientist, The First Affiliated Hospital of Chongqing Medical University
Professional Education
- Visiting Scholar, Karolinska Institutet (Per Ljungman & Markus Maeurer Lab) (2016)
- Ph. D., Peking University Health Science Centre (2009)
- B.Med., Tongji Medical College, Huazhong University of Science and Technology (2001)
Selected Publications:
- Luo XH*, Zhu Y, Duan XQ, Peng W, Pei CX, Yang L, Li Q, Zhao M, Wang L. Histone HIST1 genes and tumor-infiltrating lymphocytes in a child with γδ T cell acute lymphoblastic leukemia by single-cell sequencing. Journal of Leukocyte Biology. 2025 Apr;117(4):qiaf022.
- Shui LP, Zhu Y, Duan XQ, Chen YT, Yang L, Tang XQ, Zhang HB, Xiao Q, Wang L, Liu L, Luo XH*. HBsAg (‐)/HBsAb (‐)/HBeAg (‐)/HBeAb (+)/HBcAb (+) predicts a high risk of hepatitis B reactivation in patients with B ‐ cell lymphoma receiving rituximab based immunochemotherapy. Journal of Medical Virology. 2023 Feb 3.
- Luo XH*, Poiret T, Liu Z, Meng Q, Nagchowdhury A, Ljungman P. Different recovery patterns of CMV-specific and WT1-specific T cells in patients with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation: Impact of CMV infection and leukemia relapse. Frontiers in Immunology. 2022;13.
- Luo XH*, Meng Q, Liu Z, Paraschoudi G. Generation of high-affinity CMV-specific T cells for adoptive immunotherapy using IL-2, IL-15, and IL-21. Clinical Immunology. 2020 Aug 1;217:108456.
- Li S, Huang J, Zhang YL, Zhu Y, An YF, Du J, Zhang ZL, Xia Y, Liu L, Wang L, Luo XH*. Wiskott- Aldrich syndrome protein may be critical for CD8+ T cell function following MCMV infection. Cellular immunology. 2019 Apr 1;338:43-50.
- Luo XH, Meng Q, Rao M, Liu Z, Paraschoudi G, Dodoo E, Maeurer M. The impact of inflationary cytomegalovirus-specific memory T cells on anti-tumour immune responses in patients with cancer. Immunology. 2018 Nov;155(3):294-308.
- Zhenjiang L, Rao M, Luo X, Valentini D, von Landenberg A, Meng Q, Sinclair G, Hoffmann N, Karbach J, Altmannsberger HM, Jäger E. Cytokine Networks and Survivin Peptide-Specific Cellular Immune Responses Predict Improved Survival in Patients With Glioblastoma Multiforme. EBioMedicine. 2018 Jul 1;33:49-56.
- Liu Zhenjiang, Martin Rao, Xiaohua Luo, Elisabeth Sandberg, Jiri Bartek Jr, Esther Schoutrop, Anna von Landenberg, Qingda Meng, Davide Valentini, Thomas Poiret, Georges Sinclair, Inti- Harvey Peredo, Ernest Dodoo, and Markus Maeurer*. Mesothelin-specific Immune Responses Predict Survival of Patients With Brain Metastasis. EBioMedicine. 2017 Sep; 23: 20–24.
- Liu Z, Poiret T, Persson O, Meng Q, Rane L, Bartek J, Karbach J, Altmannsberger HM, Illies C, Luo X, Harvey-Peredo I. NY-ESO-1-and survivin-specific T-cell responses in the peripheral blood from patients with glioma. Cancer Immunology, Immunotherapy. 2018 Feb 1;67(2):237- 46.
- Liu Z, Meng Q, Bartek Jr J, Poiret T, Persson O, Rane L, Rangelova E, Illies C, Peredo IH, Luo X, Rao MV. Tumor-infiltrating lymphocytes (TILs) from patients with glioma. Oncoimmunology. 2017 Feb 1;6(2):e1252894.
- XH Luo, XJ Huang*, KY Liu, LP Xu, DH Liu. Protective immunity transferred by infusion of CMV- specific CD8+ T cells within donor grafts: its associations with CMV reactivation following unmanipulated allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2010; 16(7):994-1004
- XH Luo, YJ Chang, LP Xu, DH Liu, KY Liu, XJ Huang*. The impact of graft composition on clinical outcomes in unmanipulated HLA-mismatched/haploidentical haematopoietic SCT. Bone Marrow Transplant 2009; 43(1):29-36.
